Abbreviations: TK: thymidine kinase; HSV: herpes simplex virus; VZV, varicella zoster virus; Dm: Drosophila melanogaster; dNK: deoxynucleoside kinase; dThd: thymidine; AZT: azidothymidine.
properties.
Among these mammalian deoxynucleoside kinases, two enzymes phosphorylate thymidine (dThd),
TK-1 and TK-2. The main differences between these two kinases with respect to amino acid sequences, substrate specificities, localization and levels of expression during the different cell cycle phases are summarized in Table 1 . 1, 2 Mitochondrial DNA (mtDNA) replication takes place throughout the whole cell cycle, thus constantly requiring deoxynucleoside triphosphates for mtDNA synthesis. Being active in non-proliferating tissues, TK-2 provides the nucleotides for mtDNA synthesis. Consequently, TK-2 deficiency leads to mitochondrial disorders, designated as mtDNA depletion syndromes, mostly affecting skeletal muscles. 3 Besides the mitochondrial disorders linked to TK-2 deficiency, severe mitochondrial toxicity is also associated to long-term treatment with antiviral nucleoside analogues such as AZT. 4, 5 Although the mechanism by which these nucleoside analogues exert their mitochondrial toxicity is not fully understood, it has been suggested that after phosphorylation of the nucleoside analogues by TK-2, their triphosphates accumulate in the mitochondria. In the case of AZT, phosphorylation in non-replicating cells by TK-2 is significant, despite the fact that it is not an ideal substrate for TK-2. The accumulation of AZT-TP is suggested to affect DNA-polymerase-γ, resulting in mtDNA depletion.
Likewise, mitochondrial toxicity is a major concern in the development of new nucleoside drugs as exemplified back in 1993 by the halting of a clinical trial of fialuridine (FIAU) because patients developed serious liver and kidney toxicity, later found to originate from incorporation of the drug into mitochondrial DNA.
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TK-2 inhibitors can be a valuable tool to answer the many open questions regarding the real contribution of TK-2 in the maintenance and homeostasis of mitochondrial dNTP pools and to clarify the role of this enzyme in the mitochondrial toxicity of a variety of antiviral and anticancer drugs.
Despite the lack of a crystal structure of TK-2 for structure-based inhibitor design, several TK-2 inhibitors have been identified in the past (Chart 1). A noteworthy example is the ribonucleoside 5-(E)-(2-bromovinyl)uridine (1; K i = 10.4 µM), whose 2'-deoxy congener is an alternative substrate for the enzyme. 6 Another study describes nucleosides modified at the sugar moiety, including 3'-O-alkyl analogues and 3'-hexanoylamino-3'-deoxythymidine 2, a very potent inhibitor of TK-2 (K i = 0.15 µM). Recently, we evaluated two series of thymidine analogues, which had been originally designed as M.
tuberculosis thymidylate kinase inhibitors, for their inhibitory activity against a panel of other nucleoside kinases (TK-1, TK-2, HSV-1 and VZV TK). 10 11 Several substituted 3'-thiourea derivatives of β-dThd proved highly inhibitory to and selective for human mitochondrial TK-2 compared to the other enzymes. Compound 6, which emerged as the most potent analogue of this series, inhibited TK-2 at concentrations 2,100-fold lower than those required to inhibit cytosolic TK-1 (IC 50 : TK-1: 316 µM; TK-2: 0.15 µM). Kinetic experiments indicated that this inhibitor specifically binds to the enzyme-ATP complex, and in consonance with this finding molecular modeling studies suggested that the nitrogen atoms of the thiourea group of 6 could interact favorably with the oxygens of the γ-phosphate of the cosubstrate ATP.
As it was demonstrated that the 3'-substituent of 6 and related analogues was responsible for extra interactions with TK-2 (after binding of the ATP phosphoryl donor), we decided to investigate if the thiourea moiety, earlier described as the perpetrator of toxicity, 12 The discovery that a Cu(I)-catalysed 1,3-dipolar cycloaddition reaction between azides and alkynes efficiently and regioselectively forms 1,4-substituted 1,2,3-triazoles, reported as the first "click chemistry" reaction, could be replaced by alternative linkages to connect the C-3' atom of the deoxyribose moiety to several substituents. In this study we explore thymidine analogues containing a triazole ring instead of the thiourea moiety.
13 boosted its application for lead identification and lead optimization procedures in drug discovery. 14 This Huisgen-Sharpless cycloaddition has also proven useful in the nucleoside/nucleotide field for the construction of different bioconjugates, 15 The synthesis of the 5-(E)-(2-bromovinyl) analogues is depicted in Scheme 2. After 5'-O tritylation of BVDU (9), the corresponding 2,3'-anhydro intermediate 11 was prepared by consecutive mesylation and treatment of the mesylate with Et C NMR spectra with that of the mono-substituted triazole 8a (Table 2 ). In the case of 8c, the largest resonance shift is found for the C-4" (13.0 ppm), while the shift for C-5" is relatively weak and opposite (-3.5 ppm). An opposite phenomenon is observed for 8i, where these shifts are 4.7 ppm for C-4" and 8.7 ppm for C-5". The observed downfield shifts of the substituted carbon atoms is expected given the electron withdrawing nature of the phenyl ring. The 3'-triazole-substituted dThd derivatives were evaluated for their inhibitory activity against dThd phosphorylation by recombinant purified human cytosolic TK-1, human mitochondrial TK-2, HSV-1 TK, varicella-zoster virus (VZV) TK, and Dm dNK (Table 3) In the 1,4-triazole series, the anti-TK-2 activity was clearly influenced by the nature of the substituent at C-4 of the triazole. Both a n-butyl (8b) or phenyl (8c) substituent gave submicromolar inhibition.
Introduction of a -CH . Compound 6, the most potent TK-2 inhibitor reported to date, was included as a reference.
2 -group between the triazole and the phenyl (8d) did not drastically alter the IC 50 ,
Introduction of an additional 5-(2-bromovinyl) group, known to be a privileged substituent for TK-2 binding, only slightly improved the inhibitory activity, but caused a significant increase in the selectivity for TK-2 versus TK-1 as seen from the complete lack of inhibitory effect against TK-1-catalysed dThd phosphorylation. Compound 14b showed an outstanding selectivity against TK-2 when compared to TK-1 (SI ≥ 14,000), and also is, to our knowledge, the most potent inhibitor of TK -2 reported so far, The mode of TK-2 inhibition by 14b was investigated ( Figure 1 ). First, its Ki value was determined in the presence of a fixed saturating concentration of ATP and variable concentrations of the dThd substrate. This revealed that 14b inhibited the enzyme in a purely competitive fashion and had Ki values as low as 0.012 µM. Its Ki/Km ratios were markedly lower than 1 (0.011), pointing to an affinity for the enzyme that largely exceeds the affinity of the natural substrate. Second, the Ki values of this inhibitor were also determined in the presence of a fixed saturating concentration of dThd and variable concentrations of the co-substrate ATP. Compound 14b showed a Ki value that was higher (0.41 µM)
than that observed in the presence of dThd as the variable substrate. However, the Ki/Km ratio was again much lower than 1 (0.019 µM). Interestingly, under these conditions, 14b behaved kinetically differently values of the different inhibitors fairly reflect the degree of affinity of these compounds for both enzymes. In addition, 14b showed relatively poor inhibitory activity against HSV-1 the closely related VZV TK.
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and displayed an uncompetitive mechanism of enzyme inhibition, as revealed by the (virtually) parallel kinetic lines in the Lineweaver-Burk plots.
These features point toward a specific binding of the inhibitor to an enzyme-ATP complex.
Compound 15 was synthesized to assess the compatibility of combining the thiourea moiety of 6 with a 5'-O-trityl group. Combination of the 3'-modification and the 5'-O-trityl substituent led, as expected, to an analogue that was completely devoid of affinity for TK-2.
Molecular modeling and str uctur e-activity r elationship
To gain insight into the mode of binding of this new class of inhibitors, docking experiments were undertaken using the previously reported homology-based model of TK-2 as the target. This model is largely, but not exclusively, based on many similarities with the well-characterized structure of DmdNK although two relatively major uncertainties remain: (i) the conformation of the C-terminal lowhomology His-rich loop that stabilizes the adenine ring of ATP in its binding site (as no C-terminally truncated dNK has been co-crystallized with ATP bound in the cofactor-binding site), and (ii) the precise side-chain conformation of residues making up the loop that closes the entrance to the active site and stabilizes ATP (and, in our case, also inhibitor) binding. This "lid loop" appears as a disordered region in many dNK crystal structures apparently due to its high mobility, and side-chain orientation varies depending on the nature of the molecules binding in the long active-site cleft and on the presence of an additional negative charge (e.g. sulfate ions) on the enzyme surface.
Through extrapolation from available data for Dm-dNK (in complex with drugs, substrates and 'feeback-inhibiting' deoxyribonucleoside triphosphates) we can safely assume for human TK-2 that:
-in the presence of bound ATP-Mg which in turn are crucial for the anchoring of the α and β phosphate groups, respectively, of ATP.
-the 3'-OH of the thymidine substrate can be held in place with the aid of two direct hydrogen bonds, one with the carboxylate of Glu201 and another one with the phenol of Tyr99. This latter group is further anchored due to the intervention of a water molecule that bridges additional hydrogen bonds with the hydroxyl of Tyr208 and the O2 atom of the thymine base.
The presence of a positionally equivalent water molecule and a similar extended hydrogen bonding network is a constant feature in available crystallographic structures of Dm-dNK.
-the presence of Mg 25
2+
-as previously proposed for 6 and related thiourea-derived inhibitors, bound to the ATP phosphates promotes a small displacement of the side chains of Glu81 and Glu133 with respect to their positions in the absence of this metal ion so that two carboxylate oxygens from these residues become part of the coordination sphere of the cation, which is also fixed in position by the hydroxyl of Thr64 (also hydrogen-bonded to Glu133) and two phosphate groups from ATP.
the thymine ring of β-thymidine-containing compounds can stack on the phenyl ring of Phe143 whereas O4 and N3
atoms are held in place by virtue of two highly directional hydrogen bonds with the carboxamide group of Gln110 (equivalent to Gln81 in Dm-dNK). On the other hand, a free O5'-hydroxyl of a nucleosidic ligand can be hydrogen-bonded by the guanidinium nitrogen of Arg134 and the carboxylate of Glu81, whose equivalent residues in Dm-dNK have been shown to be crucial for the phosphoryl transfer reaction. 26 An interesting observation in Dm-dNK is that when a triphosphate-Mg Thus, on the basis of the results from multiple sequence alignments (Supporting Information) and the homology-built model presented herein, Glu81 in TK-2 most likely acts as the base that deprotonates the 5'-OH of thymidine whereas Arg134 plays a crucial role in the stabilization of the transition state during the phosphoryl transfer reaction.
2+ cluster is present in the Ploop region of the ATP-binding site (e.g. from the dTTP feedback inhibitor, as in PDB entry 2VP0) the carboxylate of Glu52 (positionally and functionally equivalent to Glu81 in TK-2), which hydrogen bonds to the 5'-OH of the substrate and also to the guanidinium of Arg105 (Arg134 in TK-2) in the complexes of the enzyme with deoxynucleosides (e.g. 1J90), is slightly displaced and exchanges partners so as to enter the coordination sphere of the Mg
Taking all TK-2's conformational features into account, our best docking solution for 8f, supported and refined by subsequent MD simulation in water, suggests that the thymidine moiety of this inhibitor fills the same volume that is usually occupied by the substrate thus giving rise to the interactions described above for deoxythymidine ( Figure 2 ). In this location, the C2'-endo puckering of the sugar ring places the triazole ring at the 3' position with its nitrogens facing Glu200 (the middle Glu in the EEE lid region, and positionally and functionally equivalent to Glu171 in Dm-dNK) and the attached phenyl ring forces the side-chain of Tyr99 (the equivalent to Tyr70 in Dm-dNK), to change its orientation through a flipping motion and also displaces the bound water molecule described above.
Interestingly, interaction with the carboxylate of Glu200 happens to be mediated by a bridging water molecule that is also bonded to Arg198. As these two residues are part of the lid loop, this arrangement can account for the fact that the loop is closed over the active site and therefore the ATP molecule can get trapped. At this point it is worth noting that a 180 ion. When this happens, the guanidinium of Arg105 turns round and interacts with the phosphate group that will be transferred to the 5'-OH of the substrate as well as with the carboxylate of Glu26 (a residue that is also used to establish a strong hydrogen bond with the hydroxyl of the highly conserved Ser106 present in the ERS motif). In both conformational states, however, the buried position of the guanidinium of Arg105, which makes up the 'floor' of the triphosphate binding site under the P-loop 'ceiling', is guaranteed by a direct interaction with the carbonyl oxygen of Gly27. It is important to highlight that the model provides an explanation to the ten-fold improvement in activity that is achieved upon incorporation of the phenyl ring to the unsubstituted triazole derivative 8a.
This phenyl ring in 8f is proposed to make van der Waals interactions with Val203 and Ile204 within the VIPLEY sequence that immediately follows the lid loop so that these hydrophobic contacts can contribute to stabilization of the closed form of the enzyme. We are also aware that these proposed interactions are more favorable in TK-2 than those possible with the Cys and Val of CVPLKY in DmdNK. Taken together, sequence differences at these positions can account for the better inhibition of human TK-2 relative to Dm-dNK by the title compounds. On the other hand, comparison with 8f reveals the importance for activity of the chlorine atom at the para position (but not of the addition of a second chlorine in meta, as in compound 8g) and the deleterious effect of replacing the phenyl with a 2-pyridinyl substituent, as in compound 8h. It is also interesting to note that 14a and 14b, both containing a BVDU moiety in place of the thymine, are only marginally more potent than 8c and 8f, respectively, an observation that is in line with the facts that (i) the Km value of BVDU when used as a substrate for Dm-DNK is only ~4-fold lower than that of AZT, 25 (ii) the nucleobase-binding site in Dm-DNK and human TK2 are highly comparable, and (iii) AZT and BVDU binding to Dm-DNK show similar characteristics, as inferred from comparison of PDB structures 2JJ8 and 2VQS. Finally, our finding that a 5'-O-trityl substituent renders the inhibitors in the present series inactive is also consistent with the proposed binding mode in so far as the 5'-hydroxyl is used, as described above and reported previously for thiourea-derived inhibitors, 11 to anchor the inhibitor in the substrate binding site through hydrogen bonding interactions with the catalytically important Arg134 and Glu81.
To reveal whether the TK-2 inhibitors are able to be taken up by the cells, the most active compound 14b was chosen for further studies. Due to the lack of TK-2 gene-transduced tumor cells, human osteosarcoma cells (OST TK -) were used that were transfected with the Drosophila melanogaster multifunctional deoxynucleoside kinase gene (OST TK -/Dm dNK + ). Alike TK-2, the Dm dNK enzyme is sensitive to the inhibitory activity of compound 14b at an IC 50 of 0.46 µM ( Table 3 ). The cytostatic agents (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and 5-fluoro-2'-deoyxuridine (5FdUrd) were exposed to these cell cultures in the presence or absence of 14b (used at subtoxic concentrations (10 µM and 4 µM)) ( Table 4) . Whereas BVDU and 5FdUrd were cytostatic at an IC 50 of 0.76 and 0.066 µM, respectively, their antiproliferative effect was significantly (4-fold) decreased in the presence of 14b at 10 µM (IC 50 : 2.95 and 0.263 µM, respectively) and at 4 µM (IC 50 : 1.64 and 0.110 µM, respectively).
Thus, the conversion of BVDU and 5FdUrd to their toxic metabolite(s) by Dm dNK could be dosedependently blocked by 80% in the presence of the TK-2 (Dm dNK) inhibitor under the experimental conditions. These data revealed that the TK-2 inhibitors such as 14b can enter the intact tumor cells and be inhibitory to the nucleoside kinase present in the cytosol. It would now be imperative to investigate whether these compounds are also taken up by mitochondria after their penetration into the intact cells, enabling targeting TK-2 in the mitochondrial environment.
Conclusions
Cycloaddition of organic azides and alkynes is the most direct route to 1,2,3-triazoles. In this study, we used two different catalysts to achieve this reaction: the Cu(I) catalyst, which provided the 1,4- ] catalyst, which has recently been described for regioselective synthesis of 1,5-disubstituted 1,2,3-triazole systems.
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The direct interaction between the triazole moiety and the γ-phosphate group of ATP that was envisioned at the outset of this project was not supported by our docking and simulation studies. Instead, our results strongly suggest that the triazole appears to displace, through a flipping motion, the side- (2H, m, 5'-OH and H-3'), 6.40 (1H, app t, J= 6.6 Hz, H-1'), 7. One day later, serial dilutions of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and 5-fluoro-2'-deoyxuridine (5FdUrd) were added to the cell cultures. At day 4, cell number was counted using a
Coulter particle counter Model Z1, enabling the calculation of the 50%-inhibitory concentrations of BVDU and 5FdUrd in the presence or absence of compound 14b.
Molecular modeling.
The geometry of 8f, modelled using as a template the AZT molecule found complexed to Dm-DNK in PDB entry 2JJ8, was optimized using the B3LYP method and a 6-31G(d) basis set, as implemented in 24 the ab initio program Gaussian 03. 27 A reaction coordinate was performed to identify the two minima around the sugar-triazole bond and electrostatic potential-derived (ESP) point charges were derived using the RESP methodology. 28 The thymine ring of compound 8f was manually docked into the substrate-binding site of the previously reported 11 homology-based model of human TK-2 in complex with ATP and Mg 2+ , and the two alternative locations for the phenyl triazole substituent were explored.
Energy refinement of the resulting complexes and subsequent molecular dynamics simulations were carried out essentially as described 11 using the AMBER 10.0 suite of programs. 29 Bonded parameters for 8f were automatically assigned using the general AMBER force field (GAFF) for organic molecules. 30 The molecular system consisting of human TK-2, ATP 4-, Mg 2+ , and 8f was immersed in a truncated octahedron of ~6000 TIP3P water molecules 31 and neutralized by addition of 5 sodium ions. 32 Periodic boundary conditions were applied and electrostatic interactions were treated using the smooth particle mesh Ewald method with a grid spacing of 1 Å. The cut-off distance for the non-bonded interactions was 9 Å, the SHAKE algorithm was applied to all bonds and an integration step of 2.0 fs was used.
Firstly, solvent molecules and counter-ions were relaxed by energy minimization and allowed to redistribute around the positionally restrained enzyme-inhibitor complex (25 kcal·mol -1 ·Å -2 ) during 50 ps of molecular dynamics at constant temperature (300 K) and pressure (1 atm). These initial harmonic restraints were gradually reduced until they were completely removed and the complex was simulated for 10.0 ns in the absence of any restraints. After this time the system was progressively cooled down from 300 to 273 K over 1.2 ns and subjected to energy minimzation. The computer graphics program 
